Italy· 046339026
STEGLATRO*28 cpr rivestite 5 mg
A ertugliflozin product containing ertugliflozin, registered in Italy by MERCK SHARP & DOHME BV, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Ertugliflozin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BK04 (ertugliflozin), each read from that country’s own register.
- This record: Italy
- 7 of them publish a price we can compare per daily dose
Ertugliflozin · ATC A10BK04
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of ertugliflozin costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $2.89 in Italy to $4.50 in Switzerland — a ×1.6 gap.
- Italy: $2.89 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Ertugliflozin · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.50
- IT Italy$2.89
The record
At a glance
- Active substance
- Ertugliflozin
- Manufacturer
- MERCK SHARP & DOHME BV
- Country
- Italy (IT)
- ATC code
- A10BK04
- ATC class
- Ertugliflozin
- Defined daily dose
- 10 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic046339026STEGLATRO*28 cpr rivestite 5 mgEUR 53.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
417 interactions on record for ertugliflozin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ertugliflozin · interactions on record
417 records
- 1 severe
- 376 moderate
- 40 minor
Most severe, free to view
- SucralfateA02BX02moderate
- PapaverineA03AD01moderate
- ThiethylperazinA04AB03moderate
- TriflupromazinA04AD06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ertugliflozin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaSTEGLATROMerck Sharp & Dohme B.V., Haarlem
- SpainSTEGLATRO 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- United KingdomSteglatro 15mg tabletsMerck Sharp & Dohme (UK) Ltd
- IcelandSteglatroMerck Sharp & Dohme B.V.*
- United StatesSTEGLATROMerck Sharp & Dohme LLC
- SwitzerlandSteglatro 5 mg, FilmtablettenMSD Merck Sharp & Dohme AG
- PolandSteglatroMerck Sharp & Dohme B.V.
- SwedenSteglatro 15 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Steglatro
- Liechtenstein · Steglatro
- Norway · Steglatro
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4560910c-a679-47c8-a328-0cd78329ee05 GET /v1/drugs/4560910c-a679-47c8-a328-0cd78329ee05?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 53.3,
"source": "aifa",
"currency": "EUR",
"strength": "ERTUGLIFLOZIN 5MG 28 UNITA' USO ORALE",
"substance": "Ertugliflozin",
"equivalence_group": "KXW",
"transparency_flag": null
}See everything about ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.